Stock data

濟生 (4111)

濟生 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$117.71M, up 5.8% from a year earlier. EPS over the last four quarters totals NT$3.10.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 濟生 in Insightr